Notice of Special Interest: National Cancer Institute Administrative Supplement Opportunity for Strategies to Optimize Recruitment and Retention of Cancer Prevention and Symptom Management Clinical Trial Participants
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-21-070.html
april 27, 2021pa-20-272 - administrative supplements to existing nih grants and cooperative agreements (parent admin supp clinical trial optional)national cancer institute (nci)this notice of special interest informs current awardees of national cancer institute (nci) cancer prevention and symptom management clinical trial grants of an opportunity for supplemental funding of eligible nci-supported grant and cooperative agreement awards so that awardees can undertake and evaluate recruitment and retention strategies and thereby facilitate the success of their clinical trial programs.background:efficient recruitment and retention of diverse clinical trial participants has been notoriously difficult to achieve in all disease settings. prominent barriers to timely completion of accrual to cancer prevention and symptom management clinical trials include organizational factors (e.g., inadequate staffing, limited clinic hours, complex procedures and urban locations), participant reluctance (due to research risk concerns or limited awareness of clinical trials), logistical issues (e.g., transportation, time commitment) and objectionable protocol elements (e.g., extra clinic visits, invasive procedures, strict eligibility criteria and agent toxicity) have been. in addition, these factors along with institutional, socio-economic, and cultural disincentives contribute to the inadequate enrollment of minority and underserved populations. robust strategies are clearly needed to overcome these obstacles across all populations. furthermore, reports of rigorous evaluations of effects of recruitment and retention strategies would provide evidence-based guidance for future clinical trial recruitment planning, which is currently lacking.research objectives:the nci is providing this opportunity for support of implementation and evaluation of promising clinical trial recruitment and retention strategies for cancer prevention, cancer control, and care delivery clinical trials, as well as quality-of-life studies embedded within treatment and imaging studies. the research solicited through this opportunity includes but is not limited to strategies that are directed toward nih-designated u.s. health disparity populations, which include blacks/african americans, hispanics/latinos, american indians/alaska natives, asian americans, native hawaiians and other pacific islanders, socioeconomically disadvantaged populations, underserved rural populations, and sexual and gender minorities as well as older adult populations. research proposed for supplemental funding may include one or more strategies and may be applied to one or more studies or sites. applications should include a prospective plan to evaluate the performance of the proposal as well as the effectiveness of the proposed strategy. effectiveness of the strategy may include comparison with another strategy, participant surveys, staff satisfaction surveys or achievement of pre-specified recruitment and retention milestones.examples of the types of research strategies that may be supported through supplemental funding requested and obtained through this nosi and pa-20-272 include but are not limited to the following:applications responsive to this nosi must:applications not responsive to this nosi include those that:all applicants are encouraged to discuss their applications with the scientific/research contact listed in this nosi (below) prior to submission.applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent:pa-20-272 - administrative supplements to existing nih grants and cooperative agreements (parent admin supp clinical trial optional).all instructions in the sf424 (r&r) application guide and the funding opportunity announcement used for submission must be followed, with the following additions:eligibility and eligible individuals (program director/principal investigator):only existing awardees of the programs listed below are eligible to apply.for supplements to parent awards that include multiple program directors/principal investigators (pds/pis), the supplement may be requested by any or all of the pds/pis (in accordance with the existing leadership plan) and submitted by the awardee institution of the parent award. if the pd/pi of the supplement application is not the pd/pi of the parent award, a letter of support from the contact pi of the parent award must be provided. the project period for the parent award must be active, and cannot be in a no-cost extension, for the 1 year of the administrative supplement application/project/award.application due dates:applications can be submitted during the 6 weeks before application due dates of june 15, 2021, may 16, 2022, and may 15, 2023, until 5:00 pm local time of applicant organization, for possible funding in fy2021, fy2022, and fy2023, respectively.the expiration date of this nosi is may 16, 2023.however, continuation of this nosi is contingent upon availability of funds, and the nosi may be terminated before the current expiration date.budget:submitting applications:review and selection process:nci will conduct administrative reviews of applications and will support the most meritorious applications submitted for consideration, based upon availability of funds. additionally, nci program staff will evaluate applications using the following selection factors:please direct all inquiries to:ellen richmond, ms, gnp-bc division of cancer prevention national cancer institute telephone: 240-276-7043 e-mail: richmone@mail.nih.govweekly toc for this announcement nih funding opportunities and noticesnote: for help accessing pdf, rtf, ms word, excel, powerpoint, audio or video files, see help downloading files.